Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats

British Journal of Pharmacology
Ronald MathisonKeith A Sharkey

Abstract

The biological effects of cannabinoids (CB) are mediated by CB(1) and CB(2) receptors. The role of CB(2) receptors in the gastrointestinal tract is uncertain. In this study, we examined whether CB(2) receptor activation is involved in the regulation of gastrointestinal transit in rats. Basal and lipopolysaccharide (LPS)-stimulated gastrointestinal transit was measured after instillation of an Evans blue-gum Arabic suspension into the stomach, in the presence of specific CB(1) and CB(2) agonists and antagonists, or after treatment with inhibitors of mediators implicated in the transit process. In control rats a CB(1) (ACEA; 1 mg kg(-1)), but not a CB(2) (JWH-133; 1 mg kg(-1)), receptor agonist inhibited basal gastrointestinal transit. The effects of the CB(1) agonist were reversed by the CB(1) antagonist AM-251, which alone increased basal transit. LPS treatment increased gastrointestinal transit. This increased transit was reduced to control values by the CB(2), but not the CB(1), agonist. This inhibition by the CB(2) agonist was dose dependent and prevented by a selective CB(2) antagonist (AM-630; 1 mg kg(-1)). By evaluating the inhibition of LPS-enhanced gastrointestinal transit by different antagonists, the effects of the CB...Continue Reading

References

Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M HerkenhamK C Rice
Oct 1, 1965·The Journal of Pathology and Bacteriology·M N Walters, D A Willoughby
Jan 1, 1995·British Journal of Pharmacology·G J SouthanC Thiemermann
Feb 1, 1996·The Journal of Surgical Research·D J WirthlinK S Ephgrave
Jul 1, 1996·British Journal of Pharmacology·M A Martinez-CuestaB J Whittle
Jul 4, 1996·European Journal of Pharmacology·S J GatleyA Makriyannis
Aug 1, 1996·British Journal of Pharmacology·R G PertweeA A Coutts
Aug 1, 1997·Digestive Diseases and Sciences·P M HellströmE Theodorsson
Dec 16, 1997·Journal of Medicinal Chemistry·H Q ZhangR B Silverman
Feb 5, 1998·European Journal of Pharmacology·G GriffinR G Pertwee
May 23, 1998·Annual Review of Immunology·W P ArendC Gabay
Feb 5, 1999·Naunyn-Schmiedeberg's Archives of Pharmacology·A A IzzoF Capasso
Jul 31, 1999·Journal of Neurochemistry·C HsiehK Mackie
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·L HanusE Fride
Dec 28, 1999·European Journal of Pharmacology·A A IzzoF Capasso
Dec 6, 2000·European Journal of Pharmacology·D TanR Mathison
Dec 6, 2000·European Journal of Pharmacology·K TylerB Greenwood-Van Meerveld
Feb 22, 2001·British Journal of Pharmacology·C Lagneux, D Lamontagne
Aug 22, 2001·Pain·Philip T MalanAlexandros Makriyannis
Mar 26, 2002·Canadian Journal of Physiology and Pharmacology·M StorrH D Allescher
Jun 8, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·R G Pertwee, R A Ross
Jun 8, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·A S C RiceI Nagy
Jul 10, 2002·Gastroenterology·Luisa PintoFrancesco Capasso
Jul 13, 2002·The Journal of Comparative Neurology·Angela A CouttsSharon Anavi-Goffer
Dec 5, 2002·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·E RebollarM D Murillo
Dec 31, 2002·Chemistry and Physics of Lipids·Sonya L PalmerAlexandros Makriyannis
Jan 1, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·Wallace K MacNaughtonKeith A Sharkey

❮ Previous
Next ❯

Citations

Sep 1, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Federico MassaBeat Lutz
May 3, 2005·Nature Reviews. Immunology·Thomas W Klein
Feb 16, 2005·Current Opinion in Gastroenterology·Michael P Jones, Sarah Wessinger
Feb 8, 2006·Current Opinion in Gastroenterology·David Grundy, Michael Schemann
Aug 2, 2008·Clinical and Experimental Pharmacology & Physiology·Scott D Smid
Sep 14, 2006·Pharmacological Reviews·Pál PacherGeorge Kunos
Sep 13, 2006·Gut·V Di Marzo, A A Izzo
May 17, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Marnie DuncanKeith A Sharkey
May 28, 2010·PloS One·Alexander ChoukèrGustav Schelling
Jul 24, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Koen Van Laere
Feb 6, 2013·Prostaglandins & Other Lipid Mediators·Lauren L NicotraScott D Smid
Aug 25, 2012·Trends in Molecular Medicine·Mireille Alhouayek, Giulio G Muccioli
Feb 2, 2010·Pharmacology & Therapeutics·Angelo A Izzo, Keith A Sharkey
Jul 29, 2009·Journal of Pediatric Surgery·Tatsuru KajiDavid L Sigalet
Jul 28, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Flavia MulèRosa Serio
Jul 28, 2004·British Journal of Pharmacology·Angelo A Izzo
Oct 4, 2005·Alimentary Pharmacology & Therapeutics·M DuncanK A Sharkey
Aug 31, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A A Izzo
Sep 4, 2007·British Journal of Pharmacology·G J Sanger
Jun 2, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·K HillsleyR H Stead
Sep 12, 2006·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M SansonJ Fioramonti
Apr 1, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·D de FilippisJ G de Man
Jul 13, 2011·British Journal of Pharmacology·A AlhamoruniS E O'Sullivan
Mar 19, 2011·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J FichnaM A Storr
Oct 18, 2012·British Journal of Pharmacology·B PigottJ Garthwaite
Aug 25, 2010·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·N Percie du SertP L R Andrews
Jul 2, 2010·British Journal of Pharmacology·Brady K Atwood, Ken Mackie
Feb 6, 2010·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·R AbaloM I Martín
Feb 26, 2010·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M A StorrK A Sharkey
Oct 21, 2009·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Y-Y LiM Storr
Mar 31, 2015·Annals of Clinical and Translational Neurology·Marium ArainStan T Nakanishi
Sep 23, 2008·Clinical Neuroscience Research·Igor Grant, B Rael Cahn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved